Assessing the left atrium of childhood cancer survivors
- 1 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in The International Journal of Cardiovascular Imaging
- Vol. 37 (1), 155-162
- https://doi.org/10.1007/s10554-020-01970-x
Abstract
Survivors of childhood cancer are at risk of cancer therapy-related cardiac dysfunction (CTRCD) characterized by systolic impairment, with little known about diastolic function. Left atrial strain (LAS) is a surrogate measure of left ventricular filling. We hypothesized that survivors (1) have lower LAS versus controls, and (2) survivors exposed to higher anthracycline dosage have even lower LAS. Cross-sectional study of 45 survivors exposed to anthracyclines >= 1 year after chemotherapy and 45 healthy controls. Echo variables included mitral spectral and tissue Doppler, left ventricular ejection fraction (LV EF), LV dimension, LA volume, LV global longitudinal strain (GLS), and LAS. Peak strain (epsilon) and strain rate (SR) at three phases were obtained: atrial contraction (ac), reservoir (res), and conduit (con). Two sub-analyses of cancer survivors were performed: (1) those with anthracycline dosage >= 250 mg/m(2), and (2) those with epsilon res in the lowest quartile. On the whole, survivors had lower epsilon res and epsilon con values. The majority of survivors had relatively normal LAS, while a subset had very low LAS values and were more likely to be older. Survivors exposed to >= 250 mg/m(2)anthracycline also had lower epsilon res than those < 250 mg/m(2). There were no differences in mitral spectral/tissue Doppler, LV dimension, left atrial volume, or GLS. A subset of childhood cancer survivors have lower LAS than their healthy counterparts, while most are essentially normal. Those exposed to higher anthracycline dosage have even lower epsilon res. Longitudinal study of LAS may prove useful in monitoring for CTRCD.This publication has 34 references indexed in Scilit:
- Survivors of Childhood Cancer in the United States: Prevalence and Burden of MorbidityCancer Epidemiology, Biomarkers & Prevention, 2015
- Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular ImagingEuropean Heart Journal – Cardiovascular Imaging, 2014
- Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy.European Heart Journal – Cardiovascular Imaging, 2011
- Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohortBMJ, 2009
- Cause-Specific Late Mortality Among 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor StudyJNCI Journal of the National Cancer Institute, 2008
- Chronic Health Conditions in Adult Survivors of Childhood CancerThe New England Journal of Medicine, 2006
- Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injuryEuropean Heart Journal, 2006
- Pathophysiology of anthracycline‐ and radiation‐associated cardiomyopathies: Implications for screening and preventionPediatric Blood & Cancer, 2005
- Late Mortality Experience in Five-Year Survivors of Childhood and Adolescent Cancer: The Childhood Cancer Survivor StudyJournal of Clinical Oncology, 2001
- Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience.Journal of Clinical Oncology, 1997